维普期刊资源整合服务平台（V6.5）

22篇 您的检索式：作者名="Rech AJ"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Collapse of the CD27 + B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers 显示文摘	Carpenter EL Mick R Rech AJ	2009	Clin Cancer Res2009，15，13：	1
2	Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells显示文摘	Rech AJ Vonderheide RH	2009	Ann N Y Acad Sci2009，1174，：	1
3	Clinical use of anti-CD25 antibody daclizunlab to enhance immune responses to tumor antigen vaccination by targeting regulator7 T cells显示文摘	Rech AJ Vonderheide RH	2009	Ann N Y Acad Sci2009，1174，：	1
4	Collapse of the CD27+ B-cell compartment associated with systemic plasmacytosis in patients with advanced melanoma and other cancers显示文摘	Carpenter EL Mick R Rech AJ	2009	Clin Cancer Res2009，15，13：	1
5	CD25 blockade de- pletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients 显示文摘	Rech AJ Mick R Martin S	2012	Sci Transl Med2012，4，13：	1
6	Clinical use of anti-CD25 antibody da- clizumab to enhance immune responses to tumor antigen vaccina- tion by targeting regulatory T cells 显示文摘	Rech AJ Vonderheide RH	2009	Ann N Y Acad Sci2009，1174，：	1
7	CD25 blockade depletes and selectively reprograms regulatory T ceils in concert with immunotherapy in cancer patients 显示文摘	Rech AJ Miek R Martin S	2012	Sci Transl Med2012，4，134：	1
8	Clinical use of anti-CD25 antibody daelizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T eells显示文摘	Rech AJ Vonderheide RH	2009	Ann N Y Aead Sei2009，1174，：	1
9	Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells 显示文摘	Rech AJ Vonderheide RH	2009	Ann N Y Acad Sci2009，1174，：	1
10	Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells显示文摘	Rech AJ Vonderheide RH	2009	Ann N Y Acad Sci2009，1174，：	1
11	Clinical use of anti - CD25 an- tibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells 显示文摘	Rech AJ Vonderheide RH	2009	Ann N Y Acad Sci2009，1174，：	1
12	CD25 blockade depletes and selectively reprograms regulatory T cells in concert with irnmunotherapy in cancer patients 显示文摘	Rech AJ Mick R Martin S	2012	Sci Transl Med2012，4，134：	1
13	CD25 blockade depletes andselectively reprograms regulatory T cells in concert with immuno-therapy in cancer patients显示文摘	Rech AJ Mick H Martin S	2012	Sci Transl Med2012，4，13：	1
14	A case report of plasma exchange,steroids,mycophenolate mofetil and cyclophosphamide in acquired factor VIII inhibitors显示文摘	Rech J Hueber AJ Leipe J	2008	Ther Apher Dial2008，12，5：	1
15	CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients显示文摘	Rech AJ Mick R Martin S	2012	Sci Transl Med2012，4，13：	1
16	Clinical use of anti-CD25 antibodydaclizumab to enhance immune responses to tumor antigen vacci- nation by targeting regulatory T cells 显示文摘	Rech AJ Vonderheide RH	2009	Ann N Y Acad Sci2009，1174，：	1
17	Dynamic interplay of oncogenes and T cells induces PD-L1 in the tumor microenvironment显示文摘	Rech AJ Vonderheide RH	2013	Cancer Discoy2013，3，12：	1
18	CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immuno?therapy in cancer patients显示文摘	Rech AJ Mick R Martin S	2012	Sci Transl Med2012，4，13：	1
19	A case report of plasma exchange,steroids,mycophenolate mofetil and cyclophosphamide in acquired factor Ⅷ inhibitors显示文摘	Rech J Hueber AJ Leipe J		0，，05：	1
20	Paraneoplastic syn-drome,infection orarthritis:difficulties in diagnosis显示文摘	Hueber AJ Rech J Kallert S	2006	International journal of clinicalpractice2006，2，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示